Trademark Filing

The mark is entirely in the color green.

Mark For: This trademark registration is intended to cover the categories of biochemicals, namely, antibodies, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for in vitro scientific or research use; cells that manufacture antibody, fragment of antibody or derivatives of antibody for scientific laboratory or medical research; transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody for scientific, laboratory or medical research; host cells for scientific, laboratory or medical research. [all]

Status

2022-06-30 UTC
⟳ Refresh

DEAD REGISTRATION Cancelled Invalidated

Research	OneLook Acronym Finder
Serial Number	76491276
Registration Number	3068626
Mark Literal Elements	None
Mark Drawing Type	2 - AN ILLUSTRATION DRAWING WITHOUT ANY WORDS(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK. SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2006-02-01
Basis	1(a)
Class Status	SECTION 8 - CANCEL
Primary US Classes	001: Raw or Partly Prepared Materials 005: Adhesives 006: Chemicals and Chemical Compositions 010: Fertilizers 026: Measuring and Scientific Appliances 046: Foods and Ingredients of Foods
Primary International Class	001 - Primary Class (Chemicals) Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
Filed Use	No
Current Use	Yes
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Domestic Representative	WENDEROTH, LIND & PONACK, L.L.P.
Attorney Name	Kaushal R. Odedra, Esq.
Attorney Docket Number	TM03_037/KRO
Law Office Assigned	M60
Employee Name	EDWARDS, ALICIA COLLIN

Timeline

(CANCELLED)
IC 001. US 001 005 006 010 026 046. G & S: Biochemicals, namely, antibodies, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for in vitro scientific or research use; cells that manufacture antibody, fragment of antibody or derivatives of antibody for scientific laboratory or medical research; transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody for scientific, laboratory or medical research; host cells for scientific, laboratory or medical research. FIRST USE: 19810701. FIRST USE IN COMMERCE: 19810701(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Biochemicals, namely, antibodies, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for clinical or medical use; cells that manufacture antibody, fragment of antibody or derivatives of antibody for clinical or medical use; transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody for clinical or medical use; host cells for clinical or medical use; pharmaceuticals, namely, central nervous system depressants; preparations for ophthalmic use, anti-histaminics; cardiotonics; arrhythmia treating agents; diuretics; hypotensors; prophylactic for the treatment of asthma; antitussives and expectorants; stomachics and digestives; antacids; hormones, namely, pituitary hormones for the treatment of infertility; thyroid hormones for the treatment of hyperthyroidism; anabolic hormones for the treatment of a plastic anemia and osteoporosis; corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis; estrogen and progesterone used as combined oral contraceptives; urinary antiseptics; analgesics; anti-itching agents; cataplasms for the treatment of bruises, lumbago and stiff shoulder; pharmaceutical preparations used to treat hair disorders; vitamin preparations; food enriching agents for treating vitamin deficiencies; anti-coagulants; enzyme preparations for control of malabsorption and diarrhea; anti-cancer preparations; anti-sarcoma preparations; antibiotics and their preparations for the treatment of infectious diseases; antituberculotic agents; influenza vaccines; diphtheria vaccines; tetanus vaccines; gas gangrene vaccines, Japanese encephalitis vaccines; in vitro tetrodotoxines for medical use; antiprotozoals for the treatment of trichomoniasis and dermatophytosis; anthelmintics for the treatment of thread worm and toxoplasmaosis; naturally occurring drugs for treating peptic ulcers; charred drugs for treating peptic ulcers. moxa for treating peptic ulcers; veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs; germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use; antiseptics; drugs for arteriosclerosis; oncostatic drugs for the treatment for cancer; multi enzyme digestants for in vivo use; anti fungal antibiotics for treating trichomoniasis and dermatophytosis; antiparkinsonism drugs; minor tranquilizers; and anti anxiety agents; medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system; vitamins; anti-bacterial preparations; mucolytic preparations; medicinal preparations for the treatment of peptic ulcers; anti-inflammatory preparations; analgesic preparations; cephalosporin; cocarboxylase preparations; gluthathione preparations; preparations for improving the metabolism and the peripheral circulation; plasma substitutes and extra corporeal circulation flow improvement preparations; diuretic and anti-hypertensive preparations; in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro X-ray contrast agents for medical use, in vitro diagnostic media; pharmaceutical preparations for the treatment of insomnia and other sleep related diseases. FIRST USE: 19810701. FIRST USE IN COMMERCE: 19810701(CANCELLED)
IC 040. US 100 103 106. G & S: Custom manufacturing of antibody, fragment of antibody or derivatives of antibody; custom manufacturing of cells that manufactures antibody, fragment of antibody or derivatives of antibody; custom manufacturing of transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody; custom manufacturing of host cells. FIRST USE: 19810701. FIRST USE IN COMMERCE: 19810701(CANCELLED)
IC 042. US 100 101. G & S: Contract development for antibody, fragment of antibody or derivatives of antibody; contract development for cells that manufactures antibody, fragment of antibody or derivatives of antibody; contract development for transfected cells that manufactures antibody, fragment of antibody or derivatives of antibody; contract development for host cells. FIRST USE: 19810701. FIRST USE IN COMMERCE: 19810701